16.10.2018 • NewsElaine BurridgeSolvay

Solvay Names Diversey’s Kadri as New CEO

Solvay Names Diversey’s Kadri as New CEO
Solvay Names Diversey’s Kadri as New CEO

Solvay has appointed Ilham Kadri as its new CEO, effective from Mar. 1, 2019. Kadri, who is presently CEO and president of US hygiene technology and services company Diversey, will join Solvay on Jan. 1 and spend two months transitioning alongside incumbent CEO, Jean-Pierre Clamadieu.

Kadri has previously worked at Shell-Basell, UCB-Cytec, Huntsman and Rohm Haas-Dow Chemical. More recently, she led Diversey’s spin-off from Sealed Air to private equity group Bain Capital in 2017. She is also board member at A.O. Smith, leading global manufacturer and supplier of water heating equipment based in Milwaukee, Wisconsin, USA.

“Her knowledge of our strategic markets, strongly customer-focused mindset, her capacities to build a galvanising vision make her the leader that the group needs to accelerate its cultural transformation and unleash its growth potential,” said Nicolas Boel, chairman of Solvay’s board of directors. According to the Belgian chemicals company, "Kadri reflects Solvay's recent journey as a leading company with advanced material and specialty chemicals innovative product portfolio and sustainable solutions to address next-generation mobility and improve resource efficiency".

Clamadieu is leaving the Belgian chemicals group to take up a new position as chairman of French gas and power group Engie.

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read